Next Article in Journal
Management of egfr tki—Induced Dermatologic Adverse Events
Previous Article in Journal
Patient-Expressed Perceptions of Wait-Time Causes and Wait-Related Satisfaction
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Establishing a Clinic-Based Pancreatic Cancer and Periampullary Tumour Research Registry in Quebec

by
A.L. Smith
1,2,
C. Bascuñana
1,2,
A. Hall
1,2,
A. Salman
1,3,
A.Z. Andrei
1,2,
A. Volenik
1,2,4,
H. Rothenmund
1,2,4,
D. Ferland
1,3,
D. Lamoussenery
3,5,
A.S. Kamath
3,
R. Amre
6,
D. Caglar
6,
Z.H. Gao
6,
D.G. Haegert
6,
Y. Kanber
6,
R.P. Michel
6,
G. Omeroglu–Altinel
6,
J. Asselah
5,
N. Bouganim
5,
P. Kavan
5,
G. Arena
3,
J. Barkun
3,
P. Chaudhury
3,
S. Gallinger
7,
W.D. Foulkes
1,4,
A. Omeroglu
6,
P. Metrakos
1,3 and
G. Zogopoulos
1,2,3,4,*
add Show full author list remove Hide full author list
1
The Research Institute of the McGill University Health Centre, Montreal, QC, Canada
2
The Goodman Cancer Research Centre, McGill University, Montreal, QC, Canada
3
Hepato-Pancreato-Biliary and Transplant Surgery, McGill University Health Centre, Montreal, QC, Canada
4
Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montreal, QC, Canada
5
Hepato-Pancreato-Biliary Oncology, McGill University Health Centre, Montreal, QC, Canada
6
Department of Pathology, McGill University Health Centre, Montreal, QC, Canada
7
Hepato-Pancreato-Biliary Oncology, McGill University Health Centre, Montreal, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2015, 22(2), 113-121; https://doi.org/10.3747/co.22.2300
Submission received: 6 January 2015 / Revised: 10 February 2015 / Accepted: 11 March 2015 / Published: 1 April 2015

Abstract

Background: Enrolling patients in studies of pancreatic ductal adenocarcinoma (pdac) is challenging because of the high fatality of the disease. We hypothesized that a prospective clinic-based study with rapid ascertainment would result in high participation rates. Using that strategy, we established the Quebec Pancreas Cancer Study (qpcs) to investigate the genetics and causes of pdac and other periampullary tumours (pats) that are also rare and underrepresented in research studies. Methods: Patients diagnosed with pdac or pat were introduced to the study at their initial clinical encounter, with a strategy to enrol participants within 2 weeks of diagnosis. Patient self-referrals and referrals of unaffected individuals with an increased risk of pdac were also accepted. Family histories, epidemiologic and clinical data, and biospecimens were collected. Additional relatives were enrolled in families at increased genetic risk. Results: The first 346 completed referrals led to 306 probands being enrolled, including 190 probands affected with pdac, who represent the population focus of the qpcs. Participation rates were 88.4% for all referrals and 89.2% for pdac referrals. Family history, epidemiologic and clinical data, and biospecimens were ascertained from 91.9%, 54.6%, and 97.5% respectively of patients with pdac. Although demographics and trends in risk factors in our patients were consistent with published statistics for patients with pdac, the qpcs is enriched for families with French-Canadian ancestry (37.4%), a population with recurrent germ-line mutations in hereditary diseases. Conclusions: Using rapid ascertainment, a pdac and pat research registry with high participation rates can be established. The qpcs is a valuable research resource and its enrichment with patients of French-Canadian ancestry provides a unique opportunity for studies of heredity in these diseases.
Keywords: pancreatic cancer; periampullary tumours; research registry; cancer genetics; translational research pancreatic cancer; periampullary tumours; research registry; cancer genetics; translational research

Share and Cite

MDPI and ACS Style

Smith, A.L.; Bascuñana, C.; Hall, A.; Salman, A.; Andrei, A.Z.; Volenik, A.; Rothenmund, H.; Ferland, D.; Lamoussenery, D.; Kamath, A.S.; et al. Establishing a Clinic-Based Pancreatic Cancer and Periampullary Tumour Research Registry in Quebec. Curr. Oncol. 2015, 22, 113-121. https://doi.org/10.3747/co.22.2300

AMA Style

Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, et al. Establishing a Clinic-Based Pancreatic Cancer and Periampullary Tumour Research Registry in Quebec. Current Oncology. 2015; 22(2):113-121. https://doi.org/10.3747/co.22.2300

Chicago/Turabian Style

Smith, A.L., C. Bascuñana, A. Hall, A. Salman, A.Z. Andrei, A. Volenik, H. Rothenmund, D. Ferland, D. Lamoussenery, A.S. Kamath, and et al. 2015. "Establishing a Clinic-Based Pancreatic Cancer and Periampullary Tumour Research Registry in Quebec" Current Oncology 22, no. 2: 113-121. https://doi.org/10.3747/co.22.2300

APA Style

Smith, A. L., Bascuñana, C., Hall, A., Salman, A., Andrei, A. Z., Volenik, A., Rothenmund, H., Ferland, D., Lamoussenery, D., Kamath, A. S., Amre, R., Caglar, D., Gao, Z. H., Haegert, D. G., Kanber, Y., Michel, R. P., Omeroglu–Altinel, G., Asselah, J., Bouganim, N., ... Zogopoulos, G. (2015). Establishing a Clinic-Based Pancreatic Cancer and Periampullary Tumour Research Registry in Quebec. Current Oncology, 22(2), 113-121. https://doi.org/10.3747/co.22.2300

Article Metrics

Back to TopTop